Table 2.
Best response rate by mRCC histology in patients with evaluable response (n = 21).
| Clear cell | Non-Clear cell | Total | |||
|---|---|---|---|---|---|
| (n = 11) | (n = 10) | (n = 21) | |||
| Papillary | Unclassified | Translocation | |||
| (n = 7*) | (n = 2) | (n = 1) | |||
| ORR | 6 (29%) | 1 (5%) | - | - | 7 (33%) |
| CR | 1 (5%) | 1 (5%) | - | - | 2 (10%) |
| PR | 5 (24%) | - | - | - | 5 (24%) |
| SD | 2 (10%) | 3 (14%) | 1 (5%) | - | 6 (29%) |
| PD | 3 (14%) | 3 (14%) | 1 (5%) | 1 (5%) | 8 (38%) |
This group includes three patients with clear cell component.